Actavis, Forest Laboratories receive request for additional information from FTC

DUBLIN  — Actavis and Forest Laboratories on Thursday announced that they have each received a request for additional information from the Federal Trade Commission in connection with Actavis' pending acquisition of Forest. 

The effect of the second request is to extend the waiting period until 30 days after Actavis and Forest have substantially complied with the request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC.  

Actavis and Forest intend to cooperate fully with the FTC and they continue to expect the transaction to close in mid-year 2014.